CabergolineCAS81409-90-7

Carbergolin, a ergot alkaloid derivative, is a dopamine receptor agonist with similar effect to bromocriptine. Its characteristics are strong, long-acting and selective, and it has high affinity with D2 dopamine receptor. It has a strong and lasting inhibitory effect on the secretion of mammary gland

It is mainly used in Parkinson's disease, Parkinson's syndrome and hyperprolactinemia. This product can reduce the severity of "on-off phenomenon" caused by long-term use of levodopa, increase the time of "on" state significantly, and reduce the requirement of levodopa by 18%.

1、 For early and late Parkinson's disease;

2、 It is used for hyperprolactinism caused by primary and trabecular pituitary adenomas;

3、 Inhibition of physiological lactation and treatment of hyperprolactinemia related diseases.